What is OneStart?
OneStart is the world’s largest life sciences and healthcare startup accelerator program – welcoming ideas focused on the improvement of human health including; therapeutics, diagnostics, software, devices, research tools, and more.
Our focus is it to cultivate early-stage entrepreneurship among young and disruptive healthcare innovators and to that end we limit the participation of applicants to 35 years old or younger.
We welcome ideas and businesses at all stages of development, from the very early to more mature. Our programme provides extensive mentoring and support up to 70 teams each year (not just the winner). As a result, each year multiple entrants secure follow-on funding.
There is absolutely no cost to participate, and you retain full control and ownership of your business. Moreover, teams will be given access to executives from the leading pharmaceutical companies, venture capital firms, and consultancies among other resources. Current mentors come from SR One, Takeda Ventures, Bristol-Myers Squibb, GSK, Roche, AstraZeneca, MedImmune, Boehringer Ingelheim, Teva Pharmaceutical Industries, McKinsey & Co., Silicon Valley Bank, and many more
A judging panel of industry experts will award the Grand Prize to the team that has the most potential to commercialise their idea and improve the lives of patients.
The Grand Prize
The Grand Prize for OneStart Americas is US$150k, and £100k for OneStart Europe – which welcomes applications from the rest of the world (such as Asia-Pacific, Africa, Middle East, etc). Both prizes are non-dilutive and come with free lab space and extensive follow-on mentoring.
Beyond the Prize
Each year many teams (not just the winners) raise follow-on funds, often during the course of the programme – all thanks to the extensive mentoring, education and industry presence.